CDC says U.S. flu activity is falling but still elevated as of March 27, 2026. This season has brought unusually high hospitalization burden, high pediatric severity, and weaker-than-usual vaccine performance against a drifted H3N2 strain—yet vaccination and early antiviral treatment still matter right now. ([cdc.gov](https://www.cdc.gov/fluview/surveillance/2026-week-11.html))
CDC’s April 3, 2026 measles update shows higher U.S. case counts, but not a new national vaccine schedule. The practical message for families and schools is simpler: check written MMR records now, understand who may be excluded after an exposure, and move quickly if catch-up vaccination or post-exposure treatment may be needed.
A January 2026 follow-up study suggests one year of abatacept may delay rheumatoid arthritis in a narrowly defined high-risk group, but it did not prove permanent prevention or create a new plan for everyday joint aches.
Measles is still vaccine-preventable, but it spreads quickly when travel-related cases reach communities with lower local vaccination coverage. CDC says confirmed U.S. cases remain high in early 2026, and a new JAMA Network Open study suggests delayed early childhood shots can be an early warning sign that a child may also miss MMR on time.
A plain-language guide to what changed in 2026, which vaccine schedule many pediatric practices and states are using, and how coverage works now for private insurance and VFC.
CDC’s 2026 measles numbers show more than an outbreak headline. They show how quickly measles can find weak spots in community immunity, and why infants, some pregnant people, and people with severe immunocompromise may depend on others’ protection.
A new March 3, 2026 modeling study suggests breast MRI may make the most sense for people with extremely dense breasts plus higher-than-average breast cancer risk. A dense-breast notice alone does not automatically mean you need an MRI.
CMS began enforcing updated hospital price transparency requirements on April 1, 2026. Here’s what patients can actually compare before planned care, what changed in hospital price files, and why the posted number is still not a final bill.
Federal health agencies are telling people not to eat certain RAW FARM raw cheddar cheese, even though no formal recall has been issued. Here is what that means, why the warning is still urgent, and what families should do now.
A new CDC analysis found that only about 1 in 4 U.S. women ages 18 to 44 reported enough leisure-time activity to meet both federal cardio and muscle-strengthening goals. Here’s what the guidelines actually mean in plain language, why strength training is often the missing piece, and how to start without an all-or-nothing approach.
If you think someone is overdosing on opioids, do not wait to see if they wake up. Updated U.S. first-aid guidance says to call 911, give naloxone if available, support breathing, start CPR if the person is not breathing normally, and stay until help arrives.
Medicare changed how it pays for many skin substitute products used in diabetic foot ulcers in 2026, but it did not broadly stop covering care. Here’s what the change may mean for access, treatment conversations, and when to seek help.
A new federal hazard alert puts fresh attention on a serious worker-health problem in countertop fabrication: inhaling fine silica dust from engineered stone. Here is what the warning says, what California’s cases show, what symptoms matter, and why a new bill in Congress could affect legal accountability without changing the medical risk.
Measles detection is getting faster in 2026 through wastewater signals, travel-linked investigations, and county-level tracking. Here is what those tools can do, what they cannot do, and what families should do now.
CDC says this season’s flu shot offered lower-than-usual protection in adults, but that does not mean it was useless. For people 65 and older, the key steps now are to stay vaccinated, use an age-preferred shot when possible, and seek antiviral treatment quickly if symptoms begin.
With semaglutide and tirzepatide shortages resolved, the FDA is tightening scrutiny of mass-marketed compounded GLP-1s. Here is what changed and what patients should ask now.
The FDA says some telehealth companies used false or misleading marketing for compounded GLP-1 drugs. Here is what that means for patients, how compounded products differ from approved drugs, and what to check before ordering online.
The short answer is not yet. Medicare has selected Ozempic, Rybelsus, and Wegovy for drug price negotiation, but the negotiated Medicare price is not scheduled to begin until January 1, 2027. Here is what changed in 2026, why the timeline is confusing, and why your own costs can still vary by plan.
A February 11, 2026 Minnesota health advisory reported the largest known U.S. outbreak of TMVII, an emerging ringworm strain linked to intimate skin-to-skin contact. Here is what the rash can look like, why it may be mistaken for other conditions, and why some cases need testing and prescription pills rather than over-the-counter creams.
NIH says it is developing a policy framework that could make plain-language study-result summaries more routine for people in NIH-funded clinical research. Here’s what that could mean, what is still only proposed, and what patients should ask before joining a trial.
A new U.S. cholesterol guideline says some adults may need risk discussions earlier, including one-time lipoprotein(a) testing and, in select cases, treatment decisions before age 40.
A large new randomized trial found that spinal manipulation by itself did not significantly outperform guideline-based medical care for pain or disability over 1 year in adults with acute or subacute low back pain at higher risk of long-term problems. Here’s what that means for chiropractic care, self-management, and when back pain needs prompt medical evaluation.
End of content
End of content
